Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet
.

Scheidel B, Maritz MA, Gschwind YJ, Steigerwald K, Guth V, Kovacs P, Rey H.

Int J Clin Pharmacol Ther. 2017 Nov;55(11):881-890. doi: 10.5414/CP203005.

2.

Ex Vivo Assessment of Coronary Atherosclerotic Plaque by Grating-Based Phase-Contrast Computed Tomography: Correlation With Optical Coherence Tomography.

Habbel C, Hetterich H, Willner M, Herzen J, Steigerwald K, Auweter S, Schüller U, Hausleiter J, Massberg S, Reiser M, Pfeiffer F, Saam T, Bamberg F.

Invest Radiol. 2017 Apr;52(4):223-231. doi: 10.1097/RLI.0000000000000346.

PMID:
28079701
3.

Novel treatment options for juvenile idiopathic arthritis.

Steigerwald KA, Ilowite NT.

Expert Rev Clin Pharmacol. 2015;8(5):559-73. doi: 10.1586/17512433.2015.1061428. Review.

PMID:
26294075
4.

The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system.

Rechenmacher F, Steigerwald K, Laufer B, Neubauer S, Kapp TG, Li L, Mas-Moruno C, Joner M, Kessler H.

ChemMedChem. 2014 Jul;9(7):1413-8. doi: 10.1002/cmdc.201400078. Epub 2014 Apr 6.

PMID:
24706601
5.

Automatic characterization of neointimal tissue by intravascular optical coherence tomography.

Ughi GJ, Steigerwald K, Adriaenssens T, Desmet W, Guagliumi G, Joner M, D'hooge J.

J Biomed Opt. 2014 Feb;19(2):21104. doi: 10.1117/1.JBO.19.2.021104.

6.

Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.

Ammar S, Ladich E, Steigerwald K, Deisenhofer I, Joner M.

EuroIntervention. 2013 May;9 Suppl R:R89-95. doi: 10.4244/EIJV9SRA15. Review.

PMID:
23732162
7.

Tissue characterization after drug-eluting stent implantation using optical coherence tomography.

Malle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, Massberg S, Jehle J, Guagliumi G, Kastrati A, Virmani R, Byrne RA, Joner M.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1376-83. doi: 10.1161/ATVBAHA.113.301227. Epub 2013 Mar 28.

PMID:
23539216
8.

Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.

Steigerwald K, Ballke S, Quee SC, Byrne RA, Vorpahl M, Vogeser M, Kolodgie F, Virmani R, Joner M.

EuroIntervention. 2012 Oct;8(6):752-9. doi: 10.4244/EIJV8I6A115.

9.

Time does not heal all wounds: very late stent thrombosis eight years after implantation of a sirolimus-eluting stent due to positive remodelling, saccular evaginations and marked vascular inflammation.

Orban M, Joner M, Riegger J, Steigerwald K, Tada T, Ibrahim T, Laugwitz KL, Byrne RA, Kastrati A, Massberg S.

EuroIntervention. 2013 Jul;9(3):412-3. doi: 10.4244/EIJV9I3A66. No abstract available.

10.

From bench to bedside: initial experience with the Primus drug-coated balloon catheter.

Briguori C, Virmani R, Kolodgie F, Byrne RA, Steigerwald K, Orlowski M, Joner M.

Minerva Cardioangiol. 2012 Oct;60(5):507-15.

PMID:
23018430
11.

Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model.

Steigerwald K, Titova A, Malle C, Kennerknecht E, Jilek C, Hausleiter J, Nährig JM, Laugwitz KL, Joner M.

J Hypertens. 2012 Nov;30(11):2230-9. doi: 10.1097/HJH.0b013e32835821e5.

PMID:
22914572
12.

Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.

Koppara T, Joner M, Bayer G, Steigerwald K, Diener T, Wittchow E.

Thromb Haemost. 2012 Jun;107(6):1161-71. doi: 10.1160/TH12-01-0043. Epub 2012 Apr 26.

PMID:
22535188
13.

Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis.

Joner M, Radke PW, Byrne RA, Hartwig S, Steigerwald K, Leclerc G, Wittchow E.

J Biomater Appl. 2013 Feb;27(6):717-26. doi: 10.1177/0885328211423784. Epub 2012 Jan 19.

PMID:
22262578
14.

Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.

Radke PW, Joner M, Joost A, Byrne RA, Hartwig S, Bayer G, Steigerwald K, Wittchow E.

EuroIntervention. 2011 Oct 30;7(6):730-7. doi: 10.4244/EIJV7I6A116.

15.

Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.

Joner M, Byrne RA, Lapointe JM, Radke PW, Bayer G, Steigerwald K, Wittchow E.

Thromb Haemost. 2011 May;105(5):864-72. doi: 10.1160/TH10-11-0698. Epub 2011 Feb 8.

PMID:
21301785
16.

Histopathologic evaluation of nitinol self-expanding stents in an animal model of advanced atherosclerotic lesions.

Joner M, Nakazawa G, Bonsignore C, Acampado E, Steigerwald K, Merl S, Vallbracht T, Kolodgie FD, Virmani R.

EuroIntervention. 2010 Jan;5(6):737-44.

PMID:
20142227
17.

The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.

Steigerwald K, Merl S, Kastrati A, Wieczorek A, Vorpahl M, Mannhold R, Vogeser M, Hausleiter J, Joner M, Schömig A, Wessely R.

Biomaterials. 2009 Feb;30(4):632-7. doi: 10.1016/j.biomaterials.2008.10.005. Epub 2008 Nov 5.

PMID:
18990438
18.

Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.

Joner M, Morimoto K, Kasukawa H, Steigerwald K, Merl S, Nakazawa G, John MC, Finn AV, Acampado E, Kolodgie FD, Gold HK, Virmani R.

Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1960-6. doi: 10.1161/ATVBAHA.108.170662. Epub 2008 Aug 7.

PMID:
18688017
19.

The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus.

Qian J, Sarnaik AA, Bonney TM, Keirsey J, Combs KA, Steigerwald K, Acharya S, Behbehani GK, Barton MC, Lowy AM, Groden J.

Gastroenterology. 2008 Jul;135(1):152-62. doi: 10.1053/j.gastro.2008.03.074. Epub 2008 Apr 4.

20.

Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcription-independent function of APC in apoptosis.

Qian J, Steigerwald K, Combs KA, Barton MC, Groden J.

Oncogene. 2007 Jul 19;26(33):4872-6. Epub 2007 Feb 5.

PMID:
17297457
21.

The APC tumor suppressor promotes transcription-independent apoptosis in vitro.

Steigerwald K, Behbehani GK, Combs KA, Barton MC, Groden J.

Mol Cancer Res. 2005 Feb;3(2):78-89.

22.

A distinct splice form of APC is highly expressed in neurones but not commonly mutated in neuroepithelial tumours.

Steigerwald K, Santoro IM, Kordich JJ, Gismondi V, Trzepacz C, Badiali M, Giangaspero F, Balko MG, Graham JS, Ratner N, Lowy AM, Varesco L, Groden J.

J Med Genet. 2001 Apr;38(4):257-62. No abstract available.

23.

Reduced levels of mRNA for myofibrillar proteins in skeletal muscle from septic rats.

Hasselgren PO, Tricoli JV, Wieczorek D, Steigerwald KA, Angerås U, Hall-Angerås M, Fischer JE.

Life Sci. 1991;49(10):753-60.

PMID:
1875785

Supplemental Content

Loading ...
Support Center